Coding & Reimbursement

  •  - In 2018, the FDA granted breakthrough designation to the MI assay in DISCERN and FDA review is pending.

  •  - DISCERN test is covered by and paid for by Medicare Fee-for Service. 

  •  - DISCERN test has been awarded two unique CPT (PLA) codes 206U (MI & PKC) diagnostic tests and 207U (AD index) confirmatory test.

2022 Medicare Fee For Service payments
206U$2,215.40
207U$511.20